Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin

Richard J. Robbins, R. Michael Tuttle, Martin Sonenberg, Ashok Shaha, Renu Sharaf, Heather Robbins, Martin Fleisher, Steven M. Larson

Research output: Contribution to journalArticlepeer-review

87 Scopus citations


Radioiodine ablation (RA) of normal thyroid remnants after thyroidectomy for differentiated thyroid carcinoma improves the sensitivity of subsequent radioiodine scans and serum thyroglobulin measurements for detection of residual thyroid carcinoma. Local cancer recurrences are also lower after RA. One standard preparation for RA involves rendering the patient hypothyroid in order to stimulate endogenous thyrotropin (TSH) secretion and sodium iodide symporter (NIS) activity. An alternative approach is to prescribe thyroxine after thyroidectomy and to stimulate NIS with exogenous recombinant human thyrotropin (rhTSH). This latter approach was used in 10 patients at our medical center. Complete resolution of all visible 131I thyroid bed uptake was achieved in all when follow-up scans were performed 5 to 13 months later. This approach has the potential to successfully ablate thyroid remnants without the need to induce hypothyroidism.

Original languageEnglish (US)
Pages (from-to)865-869
Number of pages5
Issue number9
StatePublished - Jan 1 2001

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology


Dive into the research topics of 'Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin'. Together they form a unique fingerprint.

Cite this